{"id":127084,"date":"2025-06-23T06:00:31","date_gmt":"2025-06-23T10:00:31","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/?p=127084"},"modified":"2025-06-20T13:57:00","modified_gmt":"2025-06-20T17:57:00","slug":"cchr-demands-nursing-home-chemical-restraint-ban-and-full-accountability","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/cchr-demands-nursing-home-chemical-restraint-ban-and-full-accountability\/","title":{"rendered":"CCHR Demands Nursing Home Chemical Restraint Ban and Full Accountability"},"content":{"rendered":"

LOS ANGELES, Calif., June 23, 2025 (SEND2PRESS NEWSWIRE) — Federal health authorities are sounding the alarm over the chronic use of antipsychotic and psychotropic drugs in America\u2019s nursing homes. The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) has prioritized enforcement actions to reduce psychotropic prescribing\u2014especially among seniors with dementia. With over 15,000 facilities nationwide housing more than 1.2 million elderly residents, mental health watchdog Citizens Commission on Human Rights International (CCHR)<\/a> warns the unchecked drugging of seniors constitutes systemic elder abuse.[1]<\/p>\n

\"CCHR
Image caption: \u201cPsychotropic drugs are being used to sedate, restrain, and silence, and, as such, are a tool of oppression. CCHR asserts that this practice meets the legal definition of elder abuse and must be treated as a criminal offense.\u201d \u2013 Jan Eastgate, President CCHR International.<\/em><\/p>\n

CCHR is urging lawmakers to adopt the recommendations of a United Nations human rights expert, Claudia Mahler, who called for prohibiting chemical restraints\u2014drugs used to control behavior\u2014in aged-care settings. Mahler\u2019s report criticized the drugging of seniors in care facilities, asserting that older persons are \u201cmore likely to be deprived of liberty in care facilities than in prisons.\u201d She further warned that antipsychotic use in dementia can double the risk of death.[2]<\/p>\n

Although the National Partnership to Improve Dementia Care in Nursing Homes reported a reduction in antipsychotic use among long-stay residents\u2014from 30.1% in 2011 to 14.5% by the end of 2021\u2014those figures obscure concerning patterns of diagnosis manipulation. For instance, some nursing homes labeled seniors with schizophrenia, a diagnosis virtually unheard of in the elderly, to continue prescribing antipsychotics despite federal restrictions.[3]<\/p>\n

Federal Warnings Ignored, Harm Continues<\/strong><\/p>\n

Warnings about the dangers of these drugs have spanned decades. In 2007, FDA safety official Dr. David Graham estimated at least 15,000 nursing home residents die each year due to antipsychotic use.[4] Dr. Peter G\u00f8tzsche, a Danish physician and internationally recognized expert on pharmaceutical safety, places the toll from psychiatric drugs\u2014including neuroleptics, benzodiazepines, and antidepressants\u2014at approximately 209,000 deaths annually among Americans 65 and older. Sleep medications may contribute to an additional 320,000 to 507,000 deaths per year. Even short-term use has serious consequences. Studies show that for every 100 dementia patients prescribed newer antipsychotics over just ten weeks, one will die. Combining a benzodiazepine with a neuroleptic can increase mortality risk by as much as 65%.[5]<\/p>\n

Despite federal regulations dating back to 1987 that prohibit psychotropic use for staff convenience or discipline, enforcement has been lax. In 2005, the Food and Drug Administration (FDA) issued a black-box warning linking antipsychotics to death in dementia patients prompting some prescribers to sidestep restrictions by re-diagnosing patients.[6] Between 2015 and 2019, schizophrenia diagnoses among nursing home residents rose 194%\u2014an implausible increase, attributed to efforts to preserve prescribing authority.[7]<\/p>\n

In 2021, a New York Times<\/em> investigation revealed that 21% of residents were still being given antipsychotics, often based on unsupported or false diagnoses. In 2023, the Centers for Medicare and Medicaid Services launched new measures to identify facilities inflating diagnostic codes to justify drug use\u2014but the problem persists.[8]<\/p>\n

Direct-to-Consumer (DTC) pharmaceutical advertising has also fueled drug overuse among seniors. A 2021 study found that television ads heavily influenced seniors\u2019 prescription decisions, especially in areas with high Medicare enrollment. Between 2006 and 2017, $528 million was spent promoting one antipsychotic.[9] In June 2025, the End Prescription Drug Ads Now Act was introduced to ban DTCA.<\/p>\n

Psychotropic drug use in long-term care facilities is a human rights crisis. Studies show that roughly 16% of nursing home residents experience abuse, yet only 1 in 24 cases is reported. Disturbingly, up to 40% of staff admit to having psychologically abused residents.[10]<\/p>\n

Reforms Urgently Needed<\/strong><\/p>\n

The ongoing harm inflicted on elderly residents is not an isolated lapse but a failure of oversight, ethics, and accountability, tantamount to elder abuse. CCHR urges U.S. legislators and regulators to implement such reforms as:<\/p>\n